41 studies found for:    Open Studies | "Anus Neoplasms"
Show Display Options
Rank Status Study
21 Recruiting Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer
Conditions: Squamous Carcinoma;   Head and Neck Cancer;   Anal Cancer;   Lung Cancer;   Esophageal Cancer;   Cervix Cancer
Intervention:
22 Recruiting ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy
Condition: Anal Cancer
Intervention:
23 Recruiting Cancer Research Repository for Individuals With Cancer Diagnosis and High Risk Individuals.
Conditions: Pancreatic Cancer;   Thyroid Cancer;   Lung Cancer;   Esophageal Cancer;   Thymus Cancer;   Colon Cancer;   Rectal Cancer;   GIST;   Anal Cancer;   Bile Duct Cancer;   Duodenal Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Small Intestine Cancer;   Peritoneal Surface Malignancies;   Familial Adenomatous Polyposis;   Lynch Syndrome;   Bladder Cancer;   Kidney Cancer;   Penile Cancer;   Prostate Cancer;   Testicular Cancer;   Ureter Cancer;   Urethral Cancer;   Hypopharyngeal Cancer;   Laryngeal Cancer;   Lip Cancer;   Oral Cavity Cancer;   Nasopharyngeal Cancer;   Oropharyngeal Cancer;   Paranasal Sinus Cancer;   Nasal Cavity Cancer;   Salivary Gland Cancer;   Skin Cancer;   CNS Tumor;   CNS Cancer;   Mesothelioma
Intervention:
24 Recruiting Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Conditions: Anal Carcinoma;   HIV Infection;   Human Papillomavirus Infection
Interventions: Procedure: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
25 Recruiting Nivolumab and Ipilimumab in Treating Patients With Advanced HIV Associated Solid Tumors
Conditions: Anal Carcinoma;   HIV Infection;   Kaposi Sarcoma;   Lung Carcinoma;   Solid Neoplasm
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
26 Recruiting Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Conditions: Epidermoid Carcinoma;   Anus
Interventions: Drug: radiochemotherapy;   Drug: Panitumumab
27 Recruiting Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer
Condition: Malignant Female Reproductive System Neoplasm
Interventions: Procedure: Anal Pap Test;   Procedure: Anoscopy
28 Recruiting Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma
Condition: Anal Canal Carcinoma
Intervention: Drug: Docetaxel, Cisplatin and 5-Fluorouracil
29 Recruiting Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer
Conditions: Anal Basaloid Carcinoma;   Anal Canal Cloacogenic Carcinoma;   Anal Squamous Cell Carcinoma;   Metastatic Anal Canal Carcinoma;   Recurrent Anal Canal Carcinoma;   Stage IIIB Anal Canal Cancer;   Stage IV Anal Canal Cancer
Interventions: Drug: Capecitabine;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Fluorouracil;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment
30 Recruiting HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA
Conditions: Human Papillomavirus-Related Carcinoma;   Human Papillomavirus Positive Oropharyngeal Carcinoma;   Human Papillomavirus Positive Cervical Carcinoma;   Human Papillomavirus Positive Anal Carcinoma;   Human Papillomavirus Positive Vulvar Carcinoma;   Human Papillomavirus Positive Penile Carcinoma
Intervention: Genetic: HPV Specific T Cells
31 Recruiting Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
Condition: Gastric Cancers
Intervention:
32 Recruiting Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life
Condition: Locally Advanced Anal Canal Cancer
Interventions: Drug: 5Fluorouracile and Mitomycin-C;   Radiation: Simultaneously integrated boost of intensity modulated radiation therapy (SIB-IMRT) by tomotherapy
33 Recruiting Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection
Conditions: Anal Squamous Cell Carcinoma;   HIV Infection;   Stage 0 Anal Canal Cancer;   Stage I Anal Canal Cancer
Intervention: Procedure: Therapeutic Conventional Surgery
34 Unknown  Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal Cancers
Conditions: Prostate Cancer;   Cervical Cancer;   Anal Canal Cancers
Intervention: Radiation: Intensity-Modulated Radiation Therapy
35 Recruiting Study of the Prevention of Anal Cancer
Conditions: Human Papillomavirus;   Cancer
Interventions: Procedure: Participants asked questions about recent experiences of anal intercourse in the last six months.;   Procedure: High Resolution Anoscopy
36 Recruiting Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma
Condition: Carcinoma of the Anal Canal
Interventions: Radiation: Pencil Beam scanning Radiation;   Drug: 5-fluorouracil;   Drug: Mitomycin-C
37 Unknown  Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Conditions: Neoplasms, Squamous Cell;   Papillomavirus Infections
Intervention:
38 Unknown  Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Condition: Cancer
Interventions: Drug: oxaliplatin;   Procedure: management of therapy complications
39 Recruiting Efficacy and Safety of TCA vs. ECA for the Treatment of AIN in HIV-positive Patients
Condition: Anal Intraepithelial Neoplasia (AIN) in HIV-infected Patients
Interventions: Other: Topical 85% trichloroacetic acid (TCA);   Procedure: Surgical electrocautery (ECA)
40 Recruiting Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
Condition: Advanced Cancer
Intervention: Biological: pembrolizumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results    Last Page
Indicates status has not been verified in more than two years